UNH BUY OR LONG - TARGET UP TO $380UNH confirms the "Double Bottom" pattern with a very good current buy point and a great stop loss, buy now and stop loss at: $318
UNH buy : $318
UNH target : $380
Stop loss : 6%
Wish you a good deal !
UNH trade ideas
SPHealth 2 Week Comparisons (Oct 7-20 2020)SPHealth - Growth Analysis & Comparison - Cindicator Poll Submission (October 7th - 20th 2020)
I've been looking through my Cindicator questions, making forecasts and watching markets as new polls pop up. Here's a comparison chart for 5 major S&P health companies and my rankings forecast.
(Descending order from most growth to least)
United Health Group Inc (UNH)
Abbott Labs (ABT)
Johnson & Johnson (JNJ)
Pfizer Inc. (PFE)
Merck & Co. (MRK)
This forecast will be explicitly graded by total growth % comparisons of opening prices on October 7th to closing prices on October 20th across the 5 aforementioned companies.
As of right now before 10-9-20 daily market open, the percentage growth is as follows:
UNH +1.9%
PFE +1.87%
JNJ +1.56%
ABT +1.1%
MRK +0.54%
When looking at a specific metric within the already completed duration since I submitted my forecast, overall recent growth is:
UNH +2.82%
PFE +2.66%
JNJ +2.24%
MRK +2.22%
ABT +1.62%
10-9-20 Forecast Adjustments:
Now that I have seen the last 2 days play out, I'm starting to notice a couple things about my forecast and actual live value.
I'm confident that United Health will still outperform, but this outlook could change if any major market sell off occurs before the 20th. Pfizer looks like it could be a strong runner up, and I may have flubbed my original forecast by ranking it 4th in growth. Johnson & Johnson is performing approximately as expected. Merck and Abbott Labs could be tricky to pinpoint exactly without some further research and analysis but, I'm guessing that Abbott may come in 4th place if everything settles after any quick rallies that should happen. If a light pump in Merck occurs over the 19th-20th, then there could be a small chance it outperforms Abbott for 4th but it feels like an unlikely scenario.
After these deliberations, I've decided my forecast doesn't need much adjusting other than to swap the placement of Pfizer and Abbott. My updated forecast is as follows:
United Health Group Inc (UNH)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
Abbott Labs (ABT)
Merck & Co. (MRK)
One thing to note is that I believe TradingView is not calculating its percentage scale correctly, its placing the 0% Y axis at the close value of the first candle used to calculate growth. So this graph is really just more for me to check my own work by hand, as the percentages on the left will not accurately portray what is actually being graded by Cindicator.
I'll check back in after the 20th to see how this turned out!
Thanks for tuning in :) Disclaimer, I am not responsible for any losses incurred while attempting to use my data, I hope this can prove to be some sort of learning tool for some and give insight as to how I personally come up with my own numbers. Take into full consideration this could be a completely bad forecast. Cheers
UNHSystem T Performances: Annual Compound Profit 40%, Win Rate 55%, Risk/Reward Ratio 1:2, 20 Years of Backtesting Data, Over 100 Markets.
* Click Like and Follow to Support My Work!
---
Hi Traders,
I'd like to introduce the System T, a computerized trading system that analyzed and backtested the 20 years history data of over 100 markets.
This post is my sharing of how I think about systematic trading and the signals generated by the System T.
(This is my opinion only, NOT the financial advice.)
The System T is a comprehensive system which contains many components such as buy & sell signal generator, win & loss statistics, risk control & portfolio management to make sure trading is successful in the long run.
Basically, for the system to open a trade and manage risk, it only needs a buy signal & a stop-loss signal clearly on the chart.
Once the system finds a good trend, it will ride it as long as possible. The stop-loss will be adjusted accordingly to the new price movement.
(*) Remember to follow this trade idea and follow my profile to get updates about the stop-loss adjustment and sell signal based on the latest price and market conditions daily.
System T performances above will give you an idea of how it performs in the last 20 years.
Notice that this result was achieved only if I strictly followed the rule: "Only and Always Buy & Sell based on the System Signals".
Don't sell when there is no sell signal as we all want to follow the good trends til the end like everything in life does. \(^-^)/
Also, my system is extremely diversified through over 100 markets so that it only risks less than -1% of the total capital per trade.
Thank you and good luck!
---
DISCLAIMER:
I am NOT a financial advisor, and nothing I say is meant to be a recommendation to buy or sell any financial instrument.
My views are general in nature and I am not giving financial advice. You should not take my opinion as financial advice. This is my opinion only.
Do your own due diligence, and take 100% responsibility for your financial decisions.
Trading and investing are risky! Don't invest money you can't afford to lose, because many traders and investors lose money. There are no guarantees or certainties in trading.
- Content is for education purposes only, not investment advice.
- Trading involves a high degree of risk.
- We’re not investment or trading advisers.
- Nothing we say is a recommendation to buy or sell anything.
- There are no guarantees or certainties in trading.
- Many traders lose money. Don’t trade with money you can’t afford to lose.
UHN Earnings on watchLevel to watch Below 293 Blue entry for puts above 293 Blue entry for Calls
Green line max Profit Yellow line Targets
UnitedHealth Group buy signals on D1.UnitedHealth Group (UNH), daily timeframe: Uptrend looks like from a book. Support line + Hammer + Hidden Divergence
UNH - Short 60-min chart due for pullbackLooking for 312-315 to cover. Daily chart also shows overbought
UNH: Daily breakoutThis is a fantastic breakout on the daily time frame. I think it's an especially good call option play.
I went long midday and at the close. I will add on weakness tomorrow or Friday into 311.xx. I don't expect much of a pull back at all.
UNH is poised to break out - target 330-340Hi guys ,
based on what I see on my analysis , UNH is poised to break out to the upside .
Target would be around 330-340ish .
I see a daily squeeze, I see both daily and hourly moxie confirming the move and the stock is ready to post all time highs .
At this point I think we will eventually see the Dow hitting 30,000 .
UNH Breakout PotentialUNH worth a watch these upcoming weeks. Holding above all notable AVWAPS. It's been consolidating for months; can see a big move on a breakout. Price action is getting tight, and the 50dma has caught up to the nearest avwap as support. Fundamentally undervalued with consensus analyst targets ranging the mid to high $300's. Watching for a clean break over $311.86
$UNH Consolidation Building up to Major Rally ?
Possible short term trade to top of the channel @ $310.
Longer term breakout trade possible on a break above channel.
4 months of consolidation should result in a nice rally to $340
Danger that election campaigning may hold the stock back.
Indicators are mixed but Accum\Dist & CMF are particularly bullish.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
UnitedHealth Group: «slow and steady wins the race»Show Me the Money! 16 July, 2020, by Vladimir Rojankovski, Chief Analyst, Grand Capital
UnitedHealth Group reported a solid quarter in which strength in premiums offset weakness routinely associated by many with COVID. The company reported $62.14 billion in revenue, a slight miss – not by a wide margin, and we tend to play it down when the company is growing its product pipeline. Q2 revenue is up 2.5% from the same period last year and drove a solid increase in net income. EPS, both adjusted and GAAP, beat consensus by double-digits to post near-100% increases from the previous year. The caveat is additional expenditures will reach the company in the 3rd quarter but not enough to impact the full-year guidance.
Technically, UnitedHealth is in ascending trend with 320 dollars as interim price target – seemingly not that much of an upside, but they call it «slow and steady wins the race».
UNITEDHEALTH GROUP is to BUY DAILYHey People, UNITEDHEALTH GROUP is in a fake bearish push, on the daily but on the 4h gives a bullish signal abortive attempt of the sellers. Its part towards its precedent above for a restest.
Please LIKE & FOLLOW, thank you!
Buy UNHIdea is buy now or till 285 for target of 310- 315. If sustain above 315 then more fireworks. 🧨 💥
Stoploss will be 275 on closing basis.
